Stock Chart
AXSM
Type: SELL growth_1yr
Strike: $165
Premium: $34.93
Expiry: Nov 19, 2027
Target: $141
Score: -100
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About AXSM - Axsome Therapeutics, Inc
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
Key Statistics
More AXSM Analysis
This AXSM stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track AXSM's price movements with trendlines, gamma walls, and key support/resistance levels.